Please provide your email address to receive an email when new articles are posted on . While current refractive surgery technologies are effective, surgeons should search for better treatments.
STAMFORD, Conn.--(BUSINESS WIRE)--TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today it raised $9.3 million in a Series A round co-led by Johnson & Johnson Innovation – ...
Please provide your email address to receive an email when new articles are posted on . TECLens is developing a non-incisional refractive correction procedure that incorporates corneal cross-linking.
Scientists have unveiled a compact optical sensor using differential guided-mode resonance that achieves record sensitivity in detecting refractive index changes. Their sensor opens new possibilities ...